Naoko Wada

2.3k total citations
81 papers, 1.5k citations indexed

About

Naoko Wada is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Naoko Wada has authored 81 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 19 papers in Oncology and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Naoko Wada's work include Cancer Immunotherapy and Biomarkers (10 papers), CAR-T cell therapy research (10 papers) and Autoimmune Bullous Skin Diseases (5 papers). Naoko Wada is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), CAR-T cell therapy research (10 papers) and Autoimmune Bullous Skin Diseases (5 papers). Naoko Wada collaborates with scholars based in Japan, United States and Netherlands. Naoko Wada's co-authors include Hiroshi Uchi, Jun‐ichi Matsuda, Hiroaki Mitsuya, Yutaka Okuno, Hiroyuki Hata, Shiho Fujiwara, Yawara Kawano, Kou‐ichi Jishage, Masutaka Furue and Masayuki Amagai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

Naoko Wada

76 papers receiving 1.5k citations

Peers

Naoko Wada
Pascale Cochaux Belgium
Shuji Fukata Japan
Michael F. Walsh United States
Eiji Sugiyama Japan
Michael Brown United States
John D. Overton United States
Pierluigi Strippoli Italy
Takako Suzuki Japan
Sung K. Kim United States
Peter Donovan Australia
Pascale Cochaux Belgium
Naoko Wada
Citations per year, relative to Naoko Wada Naoko Wada (= 1×) peers Pascale Cochaux

Countries citing papers authored by Naoko Wada

Since Specialization
Citations

This map shows the geographic impact of Naoko Wada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoko Wada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoko Wada more than expected).

Fields of papers citing papers by Naoko Wada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoko Wada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoko Wada. The network helps show where Naoko Wada may publish in the future.

Co-authorship network of co-authors of Naoko Wada

This figure shows the co-authorship network connecting the top 25 collaborators of Naoko Wada. A scholar is included among the top collaborators of Naoko Wada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoko Wada. Naoko Wada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Nakaji, Shigeyuki, et al.. (2021). Prevalence and associated characteristics of aponeurotic ptosis among a general population in Japan. 71(2). 131–137. 1 indexed citations
5.
Namikawa, Kenjiro, Yoshio Kiyohara, Tatsuya Takenouchi, et al.. (2018). Efficacy and safety of nivolumab in combination with ipilimumab in Japanese patients with advanced melanoma: An open-label, single-arm, multicentre phase II study. European Journal of Cancer. 105. 114–126. 50 indexed citations
6.
Yano, Seiichi, Kenji Ashida, Hiromi Nagata, et al.. (2018). Nivolumab-induced thyroid dysfunction lacking antithyroid antibody is frequently evoked in Japanese patients with malignant melanoma. BMC Endocrine Disorders. 18(1). 36–36. 11 indexed citations
7.
Kitajima, Keiko, Kenji Ashida, Naoko Wada, et al.. (2017). Isolated ACTH deficiency probably induced by autoimmune-related mechanism evoked with nivolumab. Japanese Journal of Clinical Oncology. 47(5). 463–466. 54 indexed citations
8.
Nishimura, Nao, Shinya Endo, Shiho Fujiwara, et al.. (2017). Identification of a Compound Overcoming Drug Resistance of Myeloma Cells at Hypoxic Condition. Blood. 130. 5395–5395. 1 indexed citations
9.
Wada, Naoko, et al.. (2016). Generalised granuloma annulare associated with myelodysplastic syndrome. European Journal of Dermatology. 26(4). 410–412. 1 indexed citations
10.
Fukuzawa, Taku, Masanori Fukazawa, Otoya Ueda, et al.. (2013). SGLT5 Reabsorbs Fructose in the Kidney but Its Deficiency Paradoxically Exacerbates Hepatic Steatosis Induced by Fructose. PLoS ONE. 8(2). e56681–e56681. 45 indexed citations
11.
Hirai, Kei, et al.. (2012). Problem-Solving Therapy for Psychological Distress in Japanese Early-stage Breast Cancer Patients. Japanese Journal of Clinical Oncology. 42(12). 1168–1174. 26 indexed citations
12.
Matsuda, Shinpei, et al.. (2011). Antigen-independent development of Foxp3+ regulatory T cells suppressing autoantibody production in experimental pemphigus vulgaris. International Immunology. 23(6). 365–373. 42 indexed citations
13.
Wada, Naoko, Koji Nishifuji, Taketo Yamada, et al.. (2010). Aire-Dependent Thymic Expression of Desmoglein 3, the Autoantigen in Pemphigus Vulgaris, and Its Role in T-Cell Tolerance. Journal of Investigative Dermatology. 131(2). 410–417. 42 indexed citations
14.
Wada, Naoko, et al.. (2007). A Study on the Maintenance System of Thatched Roofs in Gokayama Ainokura Village, Japan. Journal of The Japanese Institute of Landscape Architecture. 70(5). 689–694. 5 indexed citations
15.
Wada, Naoko, Toyojiro Matsuishi, Michiko Nonaka, Etsuo Naito, & Makoto Yoshino. (2003). Pyruvate dehydrogenase E1α subunit deficiency in a female patient: evidence of antenatal origin of brain damage and possible etiology of infantile spasms. Brain and Development. 26(1). 57–60. 29 indexed citations
16.
Matsumoto, Kenji, Naoko Wada, K. Sera, et al.. (2003). Antitumor effect of arsenic trioxide in murine xenograft model. Cancer Science. 94(11). 1010–1014. 33 indexed citations
17.
Yamashita, Yushiro, et al.. (1999). Effects of Indomethacin and Hyperventilation on Cerebral Hemodynamics and Oxygenation in Newborn Piglets.. The Kurume Medical Journal. 46(3/4). 137–141. 1 indexed citations
18.
Tanaka, Ken-ichi, Naoko Wada, Koji Hori, et al.. (1998). Chronic cerebral hypoperfusion disrupts discriminative behavior in acquired-learning rats. Journal of Neuroscience Methods. 84(1-2). 63–68. 19 indexed citations
19.
Yamashita, Yushiro, et al.. (1997). Heat stroke-like episode in a child caused by zonisamide. Brain and Development. 19(5). 366–368. 27 indexed citations
20.
Nakazawa, Miki, et al.. (1997). A Monoclonal Antibody Affects Chromophore Apoprotein Interactions of Phytochrome A. Photochemistry and Photobiology. 65(4). 745–749. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pascale Cochaux Breakdown of academic impact, for papers by Shuji Fukata Breakdown of academic impact, for papers by Michael F. Walsh Breakdown of academic impact, for papers by Eiji Sugiyama Breakdown of academic impact, for papers by Michael Brown Breakdown of academic impact, for papers by John D. Overton Breakdown of academic impact, for papers by Pierluigi Strippoli Breakdown of academic impact, for papers by Takako Suzuki Breakdown of academic impact, for papers by Sung K. Kim Breakdown of academic impact, for papers by Peter Donovan
Rankless by CCL
2026